XML 37 R30.htm IDEA: XBRL DOCUMENT v3.25.4

The Company and Basis of Presentation (Tables)

6 Months Ended

Dec. 31, 2025

The Company and Basis of Presentation [Abstract]

Schedule of Company’s Entity Structure at the End of the Reporting Period

Details of the Company’s entity structure at the end of the reporting period are as follows (post-redomiciliation):

Name		Entity		Country of Incorporation
Neuphoria Therapeutics Inc.		Parent		United States
Bionomics Limited		Subsidiary		Australia
Bionomics, Inc.		Subsidiary		United States

X

- References

No definition available.

+ Details

Name:	us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the key aspects of a subsidiary (partnership, corporation, or other entity) of the limited liability company or limited partnership.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration